GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?
Expert Interviews
GLP-1s are in high demand from patients, and the results are often impressive. But are there hidden risks in prescribing these drugs?
AOA President Teresa A. Hubka, DO, discusses the 2025 Match for medical students.
AOA President Teresa A. Hubka, DO, discusses the 2025 Match for medical students.
AOA President Teresa A. Hubka, DO, discusses the 2025 Match for medical students.
AOA President Teresa A. Hubka, DO, discusses the 2025 Match for medical students.
Prior authorizations are a major pain point for physicians, but technology may be able to help.
AOA President Teresa A. Hubka, DO, discusses the 2025 Match for medical students.
AOA President Teresa A. Hubka, DO, discusses the 2025 Match for medical students.
AOA President Teresa A. Hubka, DO, discusses the 2025 Match for medical students.
Prior authorizations are a major pain point for physicians, but technology may be able to help.
Prior authorizations are a major pain point for physicians, but technology may be able to help.
Prior authorizations are a major pain point for physicians, but technology may be able to help.
AOA President Teresa A. Hubka, DO, discusses the 2025 Match for medical students.
AOA President Teresa A. Hubka, DO discusses the 2025 Match for medical students.
Prior authorizations are a major pain point for physicians, but technology may be able to help.
Prior authorizations are a major pain point for physicians, but technology may be able to help.
Prior authorizations are a major pain point for physicians, but technology may be able to help.
Leah Binder, president and CEO of The Leapfrog Group, discusses the organization’s 25th anniversary and more.
Leah Binder, president and CEO of The Leapfrog Group, discusses the organization’s 25th anniversary and more.
Prior authorizations are a major pain point for physicians, but technology may be able to help.
Prior authorizations are a major pain point for physicians, but technology may be able to help.
Prior authorizations are a major pain point for physicians, but technology may be able to help.
Leah Binder, president and CEO of The Leapfrog Group, discusses the organization’s 25th anniversary and more.
Leah Binder, president and CEO of The Leapfrog Group, discusses the organization’s 25th anniversary and more.
Leah Binder, president and CEO of The Leapfrog Group, discusses the organization’s 25th anniversary and more.
Leah Binder, president and CEO of The Leapfrog Group, discusses the organization’s 25th anniversary and more.
Leah Binder, president and CEO of The Leapfrog Group, discusses the organization’s 25th anniversary and more.
Leah Binder, president and CEO of The Leapfrog Group, discusses the organization’s 25th anniversary and more.
Omid Veiseh, PhD, faculty director of the Rice Biotech Launchpad, discusses his organization’s mission to create innovative biotechnology based on patient need.
Advertisement
Advertisement
Trending on Medical Economics
1
Turkey trots; gratitude in medicine; pass the gravy, share the risk – Morning Medical Update
2
Businessman admits role in $19M DME fraud; 5 ‘eras’ of brain development; do llama’s hold the key to Alzheimer’s treatment? — Morning Medical Update
3
The regulatory changes needed to boost medtech
4
Next steps in lung cancer screening; AHRQ on tech for aging patients; calling the carcinogen committee – Morning Medical Update
5
